Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease
WEDNESDAY, July 17, 2024 -- For patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24...
Ofatumumab Effective for MS Across Racial, Ethnic Subgroups
WEDNESDAY, July 17, 2024 -- For patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic...
Disparities in Post-Acute Stroke Care Depend on Insurance Status
WEDNESDAY, July 17, 2024 -- Insurance-dependent racial and ethnic disparities and regional variations are seen in post-acute service utilization after stroke...
Familial Recurrence Rate of Autism Spectrum Disorder 20.2 Percent
WEDNESDAY, July 17, 2024 -- The familial recurrence rate of autism spectrum disorder (ASD) is 20.2 percent, which has not changed significantly from previous...
Ophthalmologic Manifestations of Acute Leukemia Are Heterogeneous
WEDNESDAY, July 17, 2024 -- Ophthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a...
Irregular Sleep Could Raise Your Odds for Diabetes
WEDNESDAY, July 17, 2024 (HeathDay News) -- Sleeping long hours one night but only a few hours the next can be unhealthy, with a new study finding "irregular"...
Feds Issue Warnings on 'Copycat' Delta-8 Products That Mimic Popular Foods
WEDNESDAY, July 17, 29024 -- In a joint effort to curb the illegal sales of food products containing delta-8 THC, the U.S. Food and Drug Administration and the...
Two Years Later, 988 Crisis Line Has Answered 10 Million Requests
WEDNESDAY, July 17, 2024 -- Just two years after the launch of the nation's three-digit crisis hotline, more than 10 million calls, texts and chat messages...
Biking, Walking to Work a Game-Changer for Health
WEDNESDAY, July 17, 2024 -- Bicycling to work can vastly improve your health and reduce your risk of death, a new study shows. People who bike commute have a...
Starving Pre-Performance Won't Bring Medals: Study
WEDNESDAY, July 17, 2024 -- Dropping weight prior to competition is a common practice among athletes. But starving oneself prior to an intense athletic event...
Orexo Receives a Complete Response Letter Regarding the NDA for OX124, a High-Dose Naloxone Rescue Medication in Development for Opioid Overdose
Uppsala, Sweden – July 16, 2024 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces that the company has received a complete response...
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
DEER PARK, Ill., July 15, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative...
FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
WESTLAKE VILLAGE, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company...
FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss
South San Francisco, CA -- July 4, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. Food and Drug...
FDA Approves Kisunla (donanemab-azbt) for the Treatment of Early Symptomatic Alzheimer's Disease
INDIANAPOLIS, July 2, 2024 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly...
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis
BOSTON--(BUSINESS WIRE)--Jul. 2, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Ahzantive (aflibercept-mrbb), a Biosimilar to Eylea
Planegg-Martinsried, Germany July 1, 2024 – Formycon AG (FSE: FYB, “Formycon”) and its licensing partner Klinge Biopharma GmbH...
FDA Approves Nypozi (filgrastim-txid), a Biosimilar to Neupogen
July 01, 2024 Tanvex BioPharma, Inc. (TWSE: 6541) announced that The U.S. Food and Drug Administration (FDA) had completed their review of our submission of...
SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN
STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on...
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
BASKING RIDGE, N.J. & RAHWAY, N.J., June 26, 2024 – The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the...
FDA Clears Investigational New Drug application for muscular dystrophy treatment
MINNEAPOLIS and ST. PAUL, Minn., July 17, 2024. Today, Myogenica, a University of Minnesota startup company, announced U.S. Food and Drug Administration...
Evommune Announces Positive Proof-of-Concept Clinical Trial Results for its MRGPRX2 Antagonist
PALO ALTO, Calf., July 16, 2024. Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated...
Supplements Slow Disease Progression During Late Stage of "Dry" Age-Related Macular Degeneration
July 16, 2024 -- In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing...
Genentech Announces Positive Phase I Results of Its Oral GLP-1 Receptor Agonist CT-996 for the Treatment of People With Obesity
South San Francisco, CA -- July 16, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from...
Sumitomo Pharma Announces that DSP-5336 Has Received FDA Fast Track Designation for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
MARLBOROUGH, Mass., July 15, 2024 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA) today announced that the U.S. Food and Drug Administration (FDA) granted...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.